News|Articles|December 10, 2015

How the Type of Antiplatelet Agents Can Impact Patient Outcomes

Christopher Betz, PharmD, BCPS, FKSHP, FASHP, professor in the department of clinical and administrative sciences at Sullivan University College of Pharmacy, discusses how the type of antiplatelet agent chosen can impact patient outcomes.

This video was recorded at the 2015 American Society of Health-System Pharmacists Midyear Meeting.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Latest CME

Webinar Registration

Advancing the Management of Hidradenitis Suppurativa: Emerging Therapies and Managed Care Strategies Across Patient Populations

Tuesday, September 1, 2026 | 1:00 & 8:00 PM EDT

Webinar Registration

Innovations in Narcolepsy Treatment: Emerging Targets and Implications for Managed Care

Thursday, September 10, 2026 | 12:10 PM-1:10 PM EDT

Webinar Registration

Evolving Treatment Options in Plaque Psoriasis: Implications of Emerging TYK2 Inhibitors for Managed Care

Thursday, September 10, 2026 | 7:00 AM – 8:00 AM EDT

Webinar Registration

Shingles Vaccination: Opportunities for Pharmacist Interventions to Provide Patient Education

Tuesday, August 25, 2026 | 1:00 PM & 8:00 PM EDT | Thursday, September 10, 2026, at 1:00 PM and 8:00 PM EDT | Tuesday, September 22, 2026 at 1:00 PM and 8:00 PM EDT

Virtual Event

Infectious Disease Day of Education 2026

Thursday, September 24, 2026

Webinar Registration

Optimizing Antibody-Drug Conjugate Safety: Pharmacist Strategies for Grading, Monitoring, and Supportive Care

Monday, October 5, 2026 | 1:00 PM & 8:00 PM EDT

On-Demand Panel Discussion

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

1.0 Credits / Breast Cancer, Oncology, Patient Safety, Women's Health

How the Type of Antiplatelet Agents Can Impact Patient Outcomes

Related Content

Why Increasing Uptake of Kidney-Protective Drugs Requires a Team

The Vaccine Schedule Just Changed Again—Here’s What's Real and What Isn't

COVID-19 Variant Surveillance: A Primer for Pharmacists Navigating Vaccine Questions

Refill Your Own Cup: Mental Well-Being and Self-Care for Pharmacy Technicians

Could Truly Water-Soluble Cannabidiol Improve Oral Dosing?

Latest CME

Advancing the Management of Hidradenitis Suppurativa: Emerging Therapies and Managed Care Strategies Across Patient Populations

Innovations in Narcolepsy Treatment: Emerging Targets and Implications for Managed Care

Evolving Treatment Options in Plaque Psoriasis: Implications of Emerging TYK2 Inhibitors for Managed Care

Shingles Vaccination: Opportunities for Pharmacist Interventions to Provide Patient Education

Infectious Disease Day of Education 2026

Optimizing Antibody-Drug Conjugate Safety: Pharmacist Strategies for Grading, Monitoring, and Supportive Care

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

Multidisciplinary Insights to Enhance Biomarker Testing Practices in Non-Small Cell Lung Cancer

Transforming Gout Care: Navigating Barriers and Therapeutic Advances in Disease Management

New Therapeutic Targets in the Treatment of Generalized Myasthenia Gravis: Understanding Disease Pathways and Pharmacist-Led Strategies for Optimized Care

Pharmacists at the Forefront: Enhancing Targeted Therapy Implementation and Patient Outcomes in Advanced Gastric Cancer

Managing Overactive Bladder in Older Adults: Challenges and Strategies for Long-Term Care

Bridging Clinical and Access Gaps in Phenylketonuria: A Managed Care Perspective

Sugar, We’re Going Down: Navigating Glycemic Control in the Era of PI3K/AKT Inhibition for Breast Cancer

Exploring Immunotherapy Strategies in Endometrial Cancer

Managing Steroid-Refractory Chronic Graft-versus-Host Disease With Novel Therapies: Opportunities for Pharmacist-Led Interventions

Collaborative Practice Agreement Implementation and Adherence: A Practical Roadmap for Oncology Pharmacists

HER2-Positive Metastatic Breast Cancer: A Managed Care Perspective on Emerging Therapies and Clinical Data

Best Practice Approaches for Understanding Chronic Obstructive Pulmonary Disease and Precision Medicine Treatment

From Payload to Patient: Managing Toxicities of Antibody-Drug Conjugates Directed at HER2 and TROP2

Advancing the Idiopathic Pulmonary Fibrosis Treatment Landscape: What’s Next in Care

Biomarker Testing in Practice: Navigating Modalities and Multidisciplinary Decision-Making

Navigating the Complexities of Personalized Prostate Cancer Care: Insights for Oncology Managed Care

Artificial Intelligence in Pharmacy Practice: Validated Tools, Real-World Applications, and Emerging Innovations (Pharmacy Technician Credit)

Artificial Intelligence in Pharmacy Practice: Validated Tools, Real-World Applications, and Emerging Innovations

Advancing HER2-Driven Cancer Care, Biomarker Testing, and Pharmacist Innovation

Navigating Outpatient Bispecific Antibody Administration in Lymphoma: Practical Solutions for Community Oncology Practices

Panel Discussion: Integrating Novel Combinations and Earlier Line Use in Diffuse Large B-Cell Lymphoma

Optimizing Patient Outcomes in R/R DLBCL: Bridging Knowledge Gaps for Oncology Pharmacists in the Era of Novel Immunotherapies

From Molecules to Medicine: Pharmacologic Principles of Innovative Non-Hodgkin Lymphoma Therapies

The Pharmacist's Role in Palliative and End of Life Symptom Management

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients (Pharmacy Technician Credit)

Understanding mRNA Vaccines: Dispelling Myths and Empowering Pharmacists to Counsel Patients

Precision Matters: Foundations of Biomarker-Driven Care in Non-Small Cell Lung Cancer

From Testing to Treatment: Empowering Pharmacists to Overcome Barriers and Optimize Biomarker-Driven Care

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians (Pharmacy Technician Credit)

Clinical Presentation of Hyperglycemia with PI3K and AKT Inhibitors

Addressing Vaccine Hesitancy in Infectious Disease Prevention

Protecting Against Meningococcal Disease: Updates on Vaccines, Guidelines, and Pharmacist Best Practices

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelines Into Managed Care Strategies

From Guidelines to Action: Implementing Pneumococcal Vaccine ACIP Recommendations in Long-Term Care Settings

Influenza Immunization in Older Adults: Enhanced Vaccines and Best Practices for Long-Term Care Pharmacists

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care

Payment for Pharmacist Services: 2025 Update

From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape

The Oncology Pharmacist's Role in Managing Small Molecule Inhibitor Use in Chronic Lymphocytic Leukemia to Enhance Patient-Centered Care

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

Redefining Care in Polycythemia Vera and Essential Thrombocythemia: Emerging Evidence, Evolving Strategies, and the Pharmacist’s Role

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models

NEIAP Conference 2026

PBMI 2026

Navigating Novel Therapies in Steroid-Refractory cGVHD: Practical Strategies for Community-Based Oncology Pharmacists

Lymphoma Day of Education 2026

Infectious Disease Day of Education 2026

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

Evolving Care in IgA Nephropathy: Translating Emerging Evidence Into Care

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

Exploring Oncolytic Viruses in Melanoma: Pharmacist-Led Approaches for Safe Integration

Enhancing The Role of Oncology Pharmacists in Multidisciplinary Myeloproliferative Neoplasm Care

Advancing Patient Safety: Strategies to Address Safety Risks and Adherence Barriers to Optimize Outcomes for Patients on Injectable Therapies

An American Journal of Managed Care Forum: Bridging Evidence and Access in Advanced Small Cell Lung Cancer

The Educated Pharmacist: Overcoming Clinical Inertia—An Interactive Case Workshop for Optimizing Insulin Use

Pharmacogenomics in Practice: Enhancing Patient Care Through Genetic Insights